77 reports

  • 3 EPIDEMIOLOGY
  • 2.2 UPCOMING REPORTS

Europe on epidemiology consulting projects.

  • Cancer
  • Immunotherapy
  • Lymphoma
  • United States
  • Forecast

Peripheral T-Cell Lymphoma (PTCL) - Market Insights, Epidemiology and Market Forecast-2027 ##.

  • Cancer
  • Lymphoma
  • Pathology
  • United States
  • Forecast

Global Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2017 ##.

  • Lymphoma
  • France
  • United States
  • World
  • Forecast

Europe Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2017 ##.

  • Lymphoma
  • Europe
  • France
  • Germany
  • Italy
  • EPIOMIC EPIDEMIOLOGY SERIES: NON-HODGKIN'S LYMPHOMA FORECAST IN 18 MAJOR MARKETS 2017-2027
  • South Africa Incidence of Non-Hodgkin's Lymphoma by 5-yr age cohort, females (000s)

Hematol Leuk. 2013; ##:##. ##.

  • Cancer
  • Lymphoma
  • North America
  • Forecast
  • Market Size
  • Epidemiology
  • B-CELL NHL: KEY METRICS IN THE 7MM

The ranking system ranges from one (##) to five (##), with ## being the least favorable score and ## being the most favorable.

  • Cancer
  • Immunotherapy
  • Lymphoma
  • United States
  • Forecast
  • 3 Epidemiology
  • 2.3 UPCOMING REPORTS

[Accessed November ##, 2015].

  • Lymphoma
  • Japan
  • United States
  • World
  • Forecast
  • Abbreviations and Acronyms used in the report
  • REFERENCES

INTRODUCTION Figure ##.

  • Cancer
  • Lymphoma
  • Pathology

Global Non-Hodgkin' s Lymphoma Epidemiology and Patient Flow Analysis - 2016 ##.

  • Cancer
  • Lymphoma
  • France
  • World
  • Forecast
  • 10.2.1.2. LYMPHOMA: INTRODUCTION AND EPIDEMIOLOGY
  • LEUKEMIA: CLASSIFICATION

INTRODUCTION AND EPIDEMIOLOGY ##. ##. ##.

  • Lymphoma
  • Company
  • Market Size
  • Juno Therapeutics Inc.
  • Novartis AG

The majority of the pipeline drugs in development are administered via the oral or intravenous routes, with only one product being tested in an intratumoral formulation.

  • Cancer
  • Lymphoma
  • Pathology
  • United States
  • World

Market Spotlight: Peripheral T-Cell Lymphoma (PTCL) CONTENTS ## OVERVIEW ## KEY TAKEAWAYS ## DISEASE BACKGROUND ## TREATMENT ## EPIDEMIOLOGY ## MARKETED DRUGS ## Approvals by country ## PIPELINE DRUGS ## KEY UPCOMING EVENTS ## LICENSING AND ASSET ACQUISITION DEALS ## Eisai Deal A Milestone On

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Forecast

Claire Herman, MPH is Global Director of Therapy Analysis and Epidemiology at GlobalData in Boston.

  • Lymphoma
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

Non-Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Lymphoma
  • France
  • United States
  • Market Shares
  • Market Size

Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Lymphoma
  • France
  • United States
  • Market Shares
  • Market Size

Claire holds a Bachelor' s degree from Wellesley College and a Master of Public Health degree in epidemiology from Boston University.

  • Lymphoma
  • United States
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Novartis AG

This cancer is the most common type of non-Hodgkin’s lymphoma (NHL), accounting for about one-third of all newly diagnosed cases.

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

The disease often initially responds to treatment, but disease relapse inevitably occurs within ##–## years.

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025 TABLE OF CONTENTS Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVERVIEW AND TRENDS ## METHODOLOGY AND MARK

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

This cancer is the most common type of non-Hodgkin’s lymphoma (NHL), accounting for about one-third of all newly diagnosed cases.

  • Lymphoma
  • European Union
  • Japan
  • United States
  • Demand

Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Lymphoma
  • France
  • Germany
  • Market Shares
  • Market Size

Non-Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Lymphoma
  • France
  • Germany
  • Market Shares
  • Market Size
  • EPIDEMIOLOGY: DIFFUSE LARGE B-CELL LYMPHOMA
  • Epidemiology: Diffuse Large B-Cell Lymphoma

PLoS One, ##(##), e##.

  • Lymphoma
  • European Union
  • Japan
  • United States
  • Roche Group

Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Lymphoma
  • Japan
  • Market Shares
  • Market Size

Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Lymphoma
  • United States
  • Market Shares
  • Market Size

Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Market Shares
  • Market Size

Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Lymphoma
  • Italy
  • Market Shares
  • Market Size

Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Lymphoma
  • Germany
  • Market Shares
  • Market Size

Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Lymphoma
  • France
  • Market Shares
  • Market Size

Non-Hodgkin Lymphoma Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Lymphoma
  • Japan
  • Market Shares
  • Market Size